IPO - Articles - Page 7

First half of 2024 marks 29% increase in med-tech fundraising year over year

July 9, 2024

In the first six months of 2024, the med-tech industry raised $13.84 billion, a 29% increase from the $10.75 billion collected during the first half of 2023. While May saw a significant $5.05 billion raised, the monthly total decreased to $1.14 billion in June.

AOTI raises £35.1M as it debuts on London’s AIM market

June 18, 2024

By Shani Alexander

Advanced Oxygen Therapy Inc. raised £35.1 million (US$44.5 million) in its initial public offering on London’s AIM market. The move by the U.S.-based company is a bid to broaden adoption of its chronic wound care technologies.

No Nasdaq for now: Radiopharma firm Telix pulls US IPO

June 14, 2024

A week after generating buzz with its proposed Nasdaq listing and plans to raise about $200 million, Telix Pharmaceuticals Ltd. withdrew its U.S. IPO filing, citing market conditions. The Australian radiopharma firm’s shares continue trading on the Australian Securities Exchange (TLX), where they closed June 14 at AU$16.61 (US$10.98), up AU15 cents.

Med-tech financings May 2024

Med-tech financings in May up more than 300% month-over-month

June 10, 2024

By Amanda Lanier

The med-tech industry has maintained its financing momentum into May, with the first five months of 2024 raising $12.7 billion, marking a 42% increase from $8.95 billion during the same period in 2023. Notably, May alone saw $5.05 billion in total med-tech financings, a 307% rise from $1.24 billion in April, and the highest monthly total reported by BioWorld MedTech since November 2022.

Telix announces $200M Nasdaq IPO to bolster radiopharma pipeline

June 7, 2024

By Tamra Sami

Australian radiopharmaceutical company Telix Pharmaceuticals Ltd. announced its IPO on the Nasdaq to raise $200 million to advance its late-stage radiopharma candidates. Headquartered in Melbourne, Telix has operations in the U.S., Europe (Belgium and Switzerland) and Japan with an extensive pipeline of theranostic radiopharmaceutical candidates.

AI-wearable, telehealth firm Seers Technology upsizes Kosdaq IPO

June 7, 2024

By Marian (YoonJee) Chu

South Korean digital health care firm Seers Technology Co. Ltd. is targeting a ₩22.1 billion (US$16.2 million) IPO on the Korea Exchange, after upping the offering price of its 1.3 million shares to ₩17,000 per share on June 4.

Med-tech financings April 2024

Med-tech financings trend higher than last year across all funding categories

May 6, 2024

By Amanda Lanier

The med-tech industry has seen a surge in financings activities in the first four months of 2024.

Med-tech financings March 2024

Med-tech financings continue to outpace last year

April 9, 2024

By Amanda Lanier

Top of FormMed-tech financings in March totaled $1.79 billion. Although a decline from February’s total, the cumulative value for the first three months of the year reached $6.02 billion, an increase from $4.69 billion during the same period the previous year.

Go BOLD: Boundless prices $100M IPO to target ecDNA-driven cancer

March 28, 2024

By Jennifer Boggs

Boundless Bio Inc. got a lukewarm welcome on Nasdaq after pricing its IPO of 6.25 million shares at the midpoint price of $16 per share, raking in about $100 million in gross proceeds to advance its pipeline of ecDNA-driven drugs targeting oncogene-amplified tumors.

Med-tech financings February 2024

Med-tech funding skyrockets more than 175% year over year

March 18, 2024

By Amanda Lanier

The med-tech financing landscape in 2024 has shown remarkable improvement over last year, with $4.62 billion raised in the initial two months, an increase of 176.62% from the $1.67 billion raised during the same period in 2023.

IPO, BioWorld MedTech
RSS

First half of 2024 marks 29% increase in med-tech fundraising year over year

AOTI raises £35.1M as it debuts on London’s AIM market

No Nasdaq for now: Radiopharma firm Telix pulls US IPO

Med-tech financings in May up more than 300% month-over-month

Telix announces $200M Nasdaq IPO to bolster radiopharma pipeline

AI-wearable, telehealth firm Seers Technology upsizes Kosdaq IPO

Med-tech financings trend higher than last year across all funding categories

Med-tech financings continue to outpace last year

Go BOLD: Boundless prices $100M IPO to target ecDNA-driven cancer

Med-tech funding skyrockets more than 175% year over year

Today's news in brief

Today's news in brief

Researchers discover how glioblastoma tumors dodge chemotherapy

Apollo’s APL-4098 shows potent antileukemic effects

HIV research is close to a cure but far from ending the pandemic

IPO, BioWorld MedTech RSS

IPO, BioWorld MedTech
RSS